Anthem is America’s 2nd largest commercial health insurer and joins more than 35 other health plans to offer coverage exclusively for the triangular iFuse Implant System SANTA CLARA, Calif., Aug. 02, ...

New positive coverage policy further validates acceptance of iFuse as an important treatment option for patients with chronic sacroiliac joint dysfunction SANTA CLARA, Calif., May 29, 2020 (GLOBE ...

SANTA CLARA, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic ...

In April 2021, SI-BONE® launched the iFuse-TORQ™ Implant System for the treatment of pelvic fractures, and for SI joint fusion. 1. The U.S. pelvic fracture market includes as many as 120,000 patients ...

Established as the market leader in the minimally invasive approach to sacroiliac (SI) joint fusion, SI-BONE, is now transitioning into a comprehensive sacropelvic solutions company. Over the past 10 ...

SANTA CLARA, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic ...

Si-Bone (($SIBN)) announced an update on their ongoing clinical study. SI-BONE, Inc. is conducting a clinical study titled ‘Pelvic Fixation and ...

SI-BONE (NASDAQ: SIBN) is a global leader in developing unique technologies for surgical treatment of sacropelvic disorders. Since pioneering minimally invasive SI joint surgery in 2009 with the iFuse ...

"We are happy to welcome Martin to our board of directors. Martin's extensive experience working with large and small commercial health plans will provide significant insight and guidance for us as we ...

SANTA CLARA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be ...

SI-BONE (NASDAQ: SIBN) is a global leader in developing unique technologies for surgical treatment of sacropelvic disorders. Since pioneering minimally invasive SI joint surgery in 2009 with the iFuse ...

SANTA CLARA, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial ...